Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Basu

Showing results (151-160 of 183) with videos related to

Pageof 19
Sort By:
Biochimie|November 1, 1988
Solubilized glycosyltransferases and biosynthesis in vitro of glycolipidsS Basu, M Basu, K K Das, et al.
Pediatric Blood & Cancer|July 31, 2021
Association of BRAF V600E mutations with vasoactive intestinal peptide syndrome in MYCN-amplified neuroblastomaSanam Shahid, Brian H Kushner, Shakeel Modak, et al.
Human & Experimental Toxicology|March 28, 2015
Salivary biochemical markers as potential acute toxicity parameters for acute radiation injury: A study on small experimental animalsS Soni, P Agrawal, N Kumar, et al.
International Journal of Cancer|August 1, 2022
Immunotherapy with anti-G<sub>D2</sub> monoclonal antibody in infants with high-risk neuroblastomaBrian H Kushner, Shakeel Modak, Kim Kramer, et al.
European Journal of Medicinal Chemistry|August 28, 2015
Design, synthesis and evaluation of thiohydantoin derivatives as potent topoisomerase I (Top1) inhibitors with anticancer activityPapiya Majumdar, Chandramohan Bathula, Suparna M Basu, et al.
European Journal of Applied Physiology and Occupational Physiology|January 1, 1995
Thyroid function during a prolonged stay in AntarcticaR C Sawhney, A S Malhotra, C S Nair, et al.
JAMA Oncology|December 22, 2022
Effect of Oral β-Glucan on Antibody Response to Ganglioside Vaccine in Patients With High-Risk Neuroblastoma: A Phase 2 Randomized Clinical TrialIrene Y Cheung, Audrey Mauguen, Shakeel Modak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2025
A Phase II Trial of Naxitamab plus Stepped-up Dosing of GM-CSF for Patients with High-Risk Neuroblastoma in First Complete RemissionBrian H Kushner, Shakeel Modak, Audrey Mauguen, et al.
Cancer|April 3, 2014
Striking dichotomy in outcome of MYCN-amplified neuroblastoma in the contemporary eraBrian H Kushner, Shakeel Modak, Kim Kramer, et al.
Pediatric Blood & Cancer|July 2, 2020
Reduced-dose craniospinal irradiation for central nervous system relapsed neuroblastomaLeo Y Luo, Kim Kramer, Nai-Kong V Cheung, et al.
Pageof 19

Showing results (151-160 of 183) with videos related to

Sort By:
Pageof 19
Biochimie|November 1, 1988
Solubilized glycosyltransferases and biosynthesis in vitro of glycolipidsS Basu, M Basu, K K Das, et al.
Pediatric Blood & Cancer|July 31, 2021
Association of BRAF V600E mutations with vasoactive intestinal peptide syndrome in MYCN-amplified neuroblastomaSanam Shahid, Brian H Kushner, Shakeel Modak, et al.
Human & Experimental Toxicology|March 28, 2015
Salivary biochemical markers as potential acute toxicity parameters for acute radiation injury: A study on small experimental animalsS Soni, P Agrawal, N Kumar, et al.
International Journal of Cancer|August 1, 2022
Immunotherapy with anti-G<sub>D2</sub> monoclonal antibody in infants with high-risk neuroblastomaBrian H Kushner, Shakeel Modak, Kim Kramer, et al.
European Journal of Medicinal Chemistry|August 28, 2015
Design, synthesis and evaluation of thiohydantoin derivatives as potent topoisomerase I (Top1) inhibitors with anticancer activityPapiya Majumdar, Chandramohan Bathula, Suparna M Basu, et al.
European Journal of Applied Physiology and Occupational Physiology|January 1, 1995
Thyroid function during a prolonged stay in AntarcticaR C Sawhney, A S Malhotra, C S Nair, et al.
JAMA Oncology|December 22, 2022
Effect of Oral β-Glucan on Antibody Response to Ganglioside Vaccine in Patients With High-Risk Neuroblastoma: A Phase 2 Randomized Clinical TrialIrene Y Cheung, Audrey Mauguen, Shakeel Modak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2025
A Phase II Trial of Naxitamab plus Stepped-up Dosing of GM-CSF for Patients with High-Risk Neuroblastoma in First Complete RemissionBrian H Kushner, Shakeel Modak, Audrey Mauguen, et al.
Cancer|April 3, 2014
Striking dichotomy in outcome of MYCN-amplified neuroblastoma in the contemporary eraBrian H Kushner, Shakeel Modak, Kim Kramer, et al.
Pediatric Blood & Cancer|July 2, 2020
Reduced-dose craniospinal irradiation for central nervous system relapsed neuroblastomaLeo Y Luo, Kim Kramer, Nai-Kong V Cheung, et al.
Pageof 19